About
About Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers serratiopeptidase, fungal lactase, peptizyme SP, nattokinase, fungal lipase, alpha galactosidase, saccharomyces boulardii, hemicellulose, papain, bromelain, fungal proteases, and bacterial alpha amylase. It also provides probiotics for human and animal nutrition. In addition, the company offers enzymes and probiotics for fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, oils and fats processing, biofuels, and specialty applications. Further, it provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is based in Thane, India.
Visit company website
5 years, 4 months ago
Advanced Enzyme Technologies Limited is currently in a long term uptrend where the price is trading 8.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 8.5.
Advanced Enzyme Technologies Limited's total revenue rose by 23.0% to $1B since the same quarter in the previous year.
Its net income has increased by 28.2% to $431M since the same quarter in the previous year.
Finally, its free cash flow grew by 8.4% to $811M since the same quarter in the previous year.
Based on the above factors, Advanced Enzyme Technologies Limited gets an overall score of 5/5.